BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6201080)

  • 1. Platelet factor 4 and beta thromboglobulin in Moya-Moya disease.
    Albala MM; Levine PH
    Am J Pediatr Hematol Oncol; 1984; 6(1):96-9. PubMed ID: 6201080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
    Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
    Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
    [No Abstract]   [Full Text] [Related]  

  • 3. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P; Cortelazzo S; Barbui T
    Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
    [No Abstract]   [Full Text] [Related]  

  • 4. Standardization of beta-thromboglobulin and platelet factor 4: a collaborative study to investigate the sources and extent of variation in the measurement of platelet specific proteins.
    Curtis AD; Kerry PJ
    Thromb Haemost; 1983 Oct; 50(3):686-9. PubMed ID: 6196853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
    Ferri GM; Afeltra A; Caccavo D; Amoroso A
    Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
    [No Abstract]   [Full Text] [Related]  

  • 6. Are platelet factor 4 and beta-thromboglobulin markers of cardiovascular disorders?
    Cella G; Scattolo N; Girolami A; Sasahara AA
    Ric Clin Lab; 1984; 14(1):9-18. PubMed ID: 6203164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the measurement of plasma beta-thromboglobulin (beta-TG) in cerebrovascular disease.
    Taomoto K; Asada M; Kanazawa Y; Matsumoto S
    Stroke; 1983; 14(4):518-24. PubMed ID: 6197783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of beta TG/PF4 ratio in patients with high platelet count.
    Fabris F; Luzzatto G; Girolami A
    Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
    [No Abstract]   [Full Text] [Related]  

  • 9. beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) in obstetrical cases.
    Arocha-Piñango CL; Ojeda A; López G; García L; Linares J
    Acta Obstet Gynecol Scand; 1985; 64(2):115-20. PubMed ID: 2580418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation and allergic asthma.
    Gresele P; Todisco T; Merante F; Nenci GG
    N Engl J Med; 1982 Mar; 306(9):549. PubMed ID: 6173752
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood levels of beta-thromboglobulin and platelet factor 4 in alcoholic liver diseases].
    Arai M
    Nihon Shokakibyo Gakkai Zasshi; 1985 Sep; 82(9):2152. PubMed ID: 2419609
    [No Abstract]   [Full Text] [Related]  

  • 12. Does the beta-TG/PF4 ratio have any value?
    Arocha-Piñango CL; Ojeda A
    Thromb Haemost; 1983 Apr; 49(2):147. PubMed ID: 6191402
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
    Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
    Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet proteins during and after prostacyclin therapy for lower limb ischaemia--suggestion of a rebound platelet activation.
    Blättler W; Furrer K; Schriber K; Kofmehl R; Massini C
    Vasa; 1981; 10(3):261-3. PubMed ID: 6169225
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study between indobufen and acetylsalicylic acid on beta-thromboglobulin, platelet factor 4 and platelet aggregation in patients with transient ischemic attacks.
    Orefice G; Carrieri P; Indaco A; Iorillo L; Fioretti A
    Acta Neurol (Napoli); 1984 Apr; 6(2):97-103. PubMed ID: 6204513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease].
    Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A; Ahmadi R
    Vasa Suppl; 1989; 27():244-6. PubMed ID: 2533741
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.
    Appiani AC; Edefonti A; Bettinelli A; Cossu MM; Paracchini ML; Rossi E
    Clin Nephrol; 1982 Apr; 17(4):195-9. PubMed ID: 6176380
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma beta-thromboglobulin and platelet factor 4 in patients with chronic renal failure and effect of hemodialysis.
    Endo Y; Mamiya S; Satoh M; Takahashi K; Harada T
    Tohoku J Exp Med; 1981 Dec; 135(4):349-58. PubMed ID: 6175048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Manzoni S; Tonin P; De Zanche L; Girolami A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():263-5. PubMed ID: 2408445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.